Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments.

VX-950 To Get Fast Tracked

December 8, 2005

Printer-friendly version

Bookmark and Share

As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another reason they are doing this is they know current therapy options are less than ideal.

UPDATE 1-Vertex hepatitis C drug will get fast track review
Thu Dec 8, 2005 11:07 AM ET

BOSTON, Dec. 8 (Reuters) - Vertex Pharmaceuticals Inc. (VRTX.O: Quote, Profile, Research) said on Thursday that U.S. regulators will review its experimental hepatitis C drug on an accelerated basis.

The Cambridge, Massachusetts-based company said the U.S. Food and Drug Administration granted "fast track" status to the drug, VX-950, a designation given to drugs aimed at treating serious or life-threatening conditions.

The drug is currently in early clinical trials and the company won't be ready to submit a marketing application until 2008, according to Joshua Boger, its chief executive officer.

Fast track status will, however, speed the drug's journey to the market as Vertex will have more frequent contact with the FDA, and it will be able to submit data from its clinical trials as it comes in, rather than waiting until the entire package is complete.

Hepatitis C is a liver disease caused by a virus in the blood. It affects about 3.4 million people in the United States.

Vertex's drug is an oral treatment that goes into the blood stream and blocks the HCV protease, a protein the hepatitis C virus makes in the liver cells. Blocking the protein prevents the virus from reproducing.

The company hopes that the drug will dramatically shorten the time it takes to eliminate the virus from the blood stream. Current treatments typically take a year to reduce the virus to undetectable levels and only work in about 50 percent of patients.

The current standard of care is a combination of pegylated interferon and ribavirin. Vertex plans to test its drug in combination with pegylated interferon next year.

Posted by Ralph at December 8, 2005 7:10 PM

Requirements for using and reposting articles

2 Comments

Ripley Author Profile Page January 25, 2006 9:00 PM

Great site, and thank you for the time you spend keeping it up.
Stay well,
Ripley

lcgsouza Author Profile Page March 7, 2006 5:29 AM

I hear VX-950 is already available in Europe. Anyone have any information about this?

Site Topics

  • Frequently Asked Questions

    Some of our most commonly asked questions and our answers to them.

  • HCV Symptoms

    You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.

  • Lab Tests

    What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.

  • Hepatitis C Genotypes

    Learn about Hepatitis C Genotypes and their variants.

  • Viral Load

    Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.

  • What is...?

    Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.

  • HCV Medicines

    Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.

  • Glossary

    Commonly used medical terms and definitions.

  • Hepatitis C Doctors

    A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.

  • Biopsy Info

    A comprehensive resource of information relating to the liver biopsy.

  • Cirrhosis

    Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.

  • Liver Cancer

    Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.

  • Liver Disease Medicines

    An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.

  • Hep-Central Email List

    Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.

  • HCV Links

    Convenient links to other sites external to Hepatitis-Central.

  • HCV Transmission

    Information about the transmission of Hepatitis C.

  • HCV Natural Remedies

    A number of herbal products useful in the management of liver disease.

  • HCV Books

    Recommended reading for those interested in hepatitis information.

  • Hepatitis C Forum

    A Bulletin Board for discussions on hepatitis, treatments, etc.

  • Hepatitis C Activism

    An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.

Advertisement